The FeLV (feline leukemia virus) vaccine typically lasts one to two years in adult cats, depending on the type of vaccine used and your cat’s risk of exposure. After the initial kitten series and a one-year booster, most cats need revaccination every one to three years for the rest of their at-risk lives.
The Initial Series and First Booster
Kittens receive two doses of the FeLV vaccine, spaced three to four weeks apart, starting as early as 8 weeks of age. This two-dose series is essential because a single shot doesn’t produce reliable, lasting immunity. The first dose primes the immune system; the second dose builds a stronger, more durable response.
Roughly 12 months after that second kitten dose, your cat needs a booster. This one-year booster is considered critical regardless of lifestyle. It reinforces the immune memory established during the initial series and sets the foundation for longer-term protection going forward. Skipping or delaying it can leave a gap in coverage during a period when young cats are most vulnerable to the virus.
How Often Adult Cats Need Boosters
After that first-year booster, the schedule splits based on how likely your cat is to encounter the virus. The 2020 AAHA/AAFP feline vaccination guidelines break it down like this:
- High-risk cats (annual boosters): Cats that go outdoors, get into fights, live with an FeLV-positive cat, or regularly encounter cats of unknown status. These cats should be revaccinated every year.
- Lower-risk cats (every 2 to 3 years): Indoor-only adult cats with minimal or occasional exposure to unfamiliar cats. The veterinary consensus recommends revaccination every two years for these cats, though some vaccine products are licensed for three-year intervals.
UC Davis School of Veterinary Medicine recommends two-yearly boosters for most cats after the initial series, adjusted for individual risk. The key point is that no FeLV vaccine provides lifelong immunity from a single course. Even low-risk cats need periodic boosters if they have any potential for exposure.
Vaccine Type Affects Duration
Two main types of FeLV vaccine are available, and they work differently under the hood.
Recombinant vaccines use a harmless canarypox virus engineered to carry FeLV proteins. These vaccines don’t contain adjuvants (chemical boosters added to stimulate a stronger immune reaction), which matters because adjuvants in cats have been linked to injection-site sarcomas, a rare but serious type of cancer. Recombinant vaccines also tend to produce immunity faster and are generally recommended as the safer option. The tradeoff is that some evidence suggests their protection may not be quite as robust as traditional vaccines, though the clinical significance of that difference is still debated.
Inactivated (killed) vaccines contain whole, dead virus and often include adjuvants. They may produce what’s called sterilizing immunity, meaning the vaccine can prevent the virus from establishing any foothold at all. According to the WSAVA, certain inactivated products are licensed for two- or even three-year booster intervals in low-risk cats, while recombinant vaccines are generally boosted annually.
Your vet will typically choose the vaccine type based on your cat’s age, health, and exposure risk. Many veterinary organizations lean toward non-adjuvanted (recombinant) products to minimize the small but real risk of injection-site reactions.
How Well the Vaccine Actually Works
When given as a proper two-dose series, the FeLV vaccine is highly effective. In a controlled study published in the Journal of the American Veterinary Medical Association, the inactivated vaccine prevented persistent viremia (the stage where the virus permanently establishes itself in the bloodstream) in 92% of vaccinated cats after direct exposure to the virus. Protection against latent infection, where the virus hides silently in bone marrow, was even higher at 96%.
What’s interesting is how the vaccine achieves this. Researchers found that vaccinated cats who successfully fought off the virus often had weak or undetectable levels of virus-neutralizing antibodies in their blood. Protection came instead from the cellular side of the immune system, specifically from specialized immune cells that recognize and destroy virus-infected cells directly. This means that a blood test showing low antibody levels after vaccination doesn’t necessarily indicate poor protection.
Testing Before Vaccination
Before your cat receives the FeLV vaccine, most vets will recommend testing for the virus first. The standard screening test detects a protein from the virus itself (not antibodies), so it works at any age and isn’t thrown off by maternal antibodies or previous vaccination. If a cat is already infected, the vaccine won’t help, and knowing the cat’s status changes how it should be managed and housed.
A single negative test is reassuring but not definitive. Cats in the very early stages of infection can test negative. When introducing a new cat to a household, a follow-up test about six weeks later helps catch infections that were too early to detect the first time around.
When Cats Can Stop Getting Boosted
Older cats that have been vaccinated throughout their lives and live strictly indoors with no exposure to unfamiliar cats are sometimes considered candidates for discontinuing FeLV boosters. The virus is most dangerous to kittens and young cats, whose immune systems are less equipped to fight it off. Cats over about two years of age have a natural, age-related resistance to progressive infection, though they aren’t completely immune.
The decision to stop boosting is a conversation between you and your vet, based on your cat’s actual lifestyle. If your indoor cat occasionally escapes, if you foster other cats, or if there’s any chance of contact with strays, continuing boosters on a risk-appropriate schedule is the safer choice.